Sankar D Navaneethan

7PUBLICATIONS

21CO-AUTHORS

Epidemiological modellingMolecular targetsPharmacogenomicsBehavioural epidemiologyInfant and child health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 05, 2026

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|Apr 15, 2026

Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease.

Abiodun Idowu, Kevin Bryan Lo, Roy Mathew

|Apr 10, 2026

Expanding Evidence for Glucagon-Like Peptide-1 Receptor Agonists in Those with Diabetes and Kidney Disease.

Michael W Holliday, Sankar D Navaneethan

|Mar 30, 2026

Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease.

Kavya Rajan, Arjun Krishen Jutley, Michael W Holliday

|Nov 12, 2025

Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study.

David C Wheeler, Kevin M Pantalone, Lixin Guo

|Sep 25, 2025

Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 Diabetes.

Michael W Holliday, Sankar D Navaneethan

Pageof 2

Frequent Collaborators

Michael W Holliday

Jefferson L Triozzi

Nan Hee Kim

Christoph Wanner

Abiodun Idowu

Roy Mathew

Rajiv Agarwal

Ricardo Correa-Rotter

1 joint publications

Hiddo J L Heerspink

1 joint publications

Matthew R Weir

Frequent Collaborators

Michael W Holliday

Jefferson L Triozzi

Nan Hee Kim

Christoph Wanner